Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

NCT05429385 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor strategy.

Conditions

COVID-19

Interventions

DRUG: HLX70
DRUG: Placebo

Sponsor

Shanghai Henlius Biotech

Collaborators

[object Object]
[object Object]
[object Object]